review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1007/S00109-006-0065-1 |
P698 | PubMed publication ID | 16773356 |
P50 | author | Melanie Greter | Q84883331 |
Burkhard Becher | Q48129628 | ||
P2093 | author name string | Ingo Bechmann | |
P2860 | cites work | IL-23 drives a pathogenic T cell population that induces autoimmune inflammation | Q29547525 |
A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17 | Q29547855 | ||
Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages | Q29547871 | ||
Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain | Q29614225 | ||
Dendritic cells: specialized and regulated antigen processing machines | Q29617085 | ||
MRI aspects of the "inflammatory phase" of multiple sclerosis. | Q30885231 | ||
The use of magnetic resonance imaging in the diagnosis and long-term management of multiple sclerosis | Q30978390 | ||
Role of autoreactive CD8+ T cells in organ-specific autoimmune diseases: insight from transgenic mouse models | Q33713291 | ||
Brain-immune connection: immuno-regulatory properties of CNS-resident cells | Q33826555 | ||
Regulation of T-cell responses by CNS antigen-presenting cells: different roles for microglia and astrocytes | Q33846443 | ||
Endogenous presentation of self myelin epitopes by CNS-resident APCs in Theiler's virus-infected mice | Q33858153 | ||
The neuroprotective effect of inflammation: implications for the therapy of multiple sclerosis. | Q33943424 | ||
Immune function of the blood-brain barrier: incomplete presentation of protein (auto-)antigens by rat brain microvascular endothelium in vitro | Q33998860 | ||
Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo | Q34049368 | ||
Immune function of microglia | Q34094707 | ||
Experimental autoimmune encephalitis and inflammation in the absence of interleukin-12 | Q34145393 | ||
Immunologically privileged sites | Q34179710 | ||
T cell mediated neuroprotection is a physiological response to central nervous system insults | Q34195673 | ||
The role of T-cell-mediated mechanisms in virus infections of the nervous system | Q34288225 | ||
Multiple sclerosis: a coordinated immunological attack against myelin in the central nervous system | Q34377314 | ||
Basic principles of immunological surveillance of the normal central nervous system | Q34398602 | ||
Apoptosis of inflammatory cells in immune control of the nervous system: role of glia | Q34398617 | ||
Central nervous system perivascular cells are immunoregulatory cells that connect the CNS with the peripheral immune system | Q34398632 | ||
Immune function of astrocytes | Q34398643 | ||
Multiple sclerosis trial designs for the 21st century: building on recent lessons | Q34463581 | ||
IL-23: a cytokine that acts on memory T cells | Q34489128 | ||
Hyperinducibility of Ia antigen on astrocytes correlates with strain-specific susceptibility to experimental autoimmune encephalomyelitis | Q34632174 | ||
Anti-inflammatory cytokines: expression and action in the brain | Q34667630 | ||
Multiple sclerosis: deeper understanding of its pathogenesis reveals new targets for therapy. | Q34674896 | ||
Immunity to homologous grafted skin; the fate of skin homografts transplanted to the brain, to subcutaneous tissue, and to the anterior chamber of the eye. | Q34853757 | ||
T cells in the central nervous system: the delicate balance between viral clearance and disease | Q34993057 | ||
Regulation and function of class II major histocompatibility complex, CD40, and B7 expression in macrophages and microglia: Implications in neurological diseases | Q35022580 | ||
Are astrocytes central players in the pathophysiology of multiple sclerosis? | Q35047645 | ||
Self-tolerance in the immune privileged CNS: lessons from the entorhinal cortex lesion model. | Q35208300 | ||
The role of CD8(+) T cells in multiple sclerosis and its animal models | Q36107655 | ||
Peripheral T cell tolerance | Q36135224 | ||
Autoreactive CD8+ T cells in multiple sclerosis: a new target for therapy? | Q36173589 | ||
IL-23 produced by CNS-resident cells controls T cell encephalitogenicity during the effector phase of experimental autoimmune encephalomyelitis. | Q36259695 | ||
Failed central nervous system regeneration: a downside of immune privilege? | Q36295983 | ||
Microglia induce CD4 T lymphocyte final effector function and death | Q36367580 | ||
Perivascular macrophages are the primary cell type productively infected by simian immunodeficiency virus in the brains of macaques: implications for the neuropathogenesis of AIDS. | Q36369228 | ||
The clinical course of experimental autoimmune encephalomyelitis and inflammation is controlled by the expression of CD40 within the central nervous system. | Q36369234 | ||
A pathogenic role for myelin-specific CD8(+) T cells in a model for multiple sclerosis | Q36376307 | ||
Myelin basic protein-specific T helper 2 (Th2) cells cause experimental autoimmune encephalomyelitis in immunodeficient hosts rather than protect them from the disease | Q36380402 | ||
Migration of Hematogenous Cells Through the Blood-Brain Barrier and the Initiation of CNS Inflammation | Q36476893 | ||
Isolation and direct characterization of resident microglial cells from the normal and inflamed central nervous system | Q37583027 | ||
Dissection of an inflammatory process induced by CD8+ T cells | Q37812033 | ||
H. polygyrus: B7-independence of the secondary type 2 response | Q39436438 | ||
Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis. | Q40453661 | ||
Pathological CNS autoimmune disease triggered by traumatic spinal cord injury: implications for autoimmune vaccine therapy. | Q40649831 | ||
Differentiated Th1 autoreactive effector cells can induce experimental autoimmune encephalomyelitis in the absence of IL-12 and CD40/CD40L interactions | Q40759046 | ||
Resident and infiltrating central nervous system APCs regulate the emergence and resolution of experimental autoimmune encephalomyelitis | Q40814343 | ||
Neuroprotection by encephalomyelitis: rescue of mechanically injured neurons and neurotrophin production by CNS-infiltrating T and natural killer cells. | Q40869638 | ||
Heterogeneity of microglial and perivascular cell populations: insights gained from the facial nucleus paradigm | Q40870400 | ||
Microglia in degenerative neurological disease. | Q40870414 | ||
Microglia derive from progenitors, originating from the yolk sac, and which proliferate in the brain | Q40917096 | ||
Microglia stimulate naive T-cell differentiation without stimulating T-cell proliferation | Q40980132 | ||
Astrocytes express elements of the class II endocytic pathway and process central nervous system autoantigen for presentation to encephalitogenic T cells | Q40991645 | ||
The central nervous system environment controls effector CD4+ T cell cytokine profile in experimental allergic encephalomyelitis | Q41077435 | ||
Activation of adult human derived microglia by myelin phagocytosis in vitro | Q41459058 | ||
Multiple sclerosis: presence of lymphatic capillaries and lymphoid tissue in the brain and spinal cord | Q41466361 | ||
Bone marrow-derived elements in the central nervous system: an immunohistochemical and ultrastructural survey of rat chimeras | Q41625499 | ||
Defining antigen-dependent stages of T cell migration from the blood to the central nervous system parenchyma | Q48971811 | ||
Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis. | Q49014751 | ||
Initiation of immune responses in brain is promoted by local dendritic cells. | Q50796487 | ||
Repertoire dynamics of autoreactive T cells in multiple sclerosis patients and healthy subjects: epitope spreading versus clonal persistence. | Q52028997 | ||
Distinct inflammatory stimuli induce different patterns of myelin phagocytosis and degradation in recruited macrophages. | Q52542047 | ||
Presence of B7--2 (CD86) and lack of B7--1 (CD(80) on myelin phagocytosing MHC-II-positive rat microglia is associated with nondestructive immunity in vivo. | Q52965148 | ||
Multiple sclerosis: oligodendrocytes in active lesions do not express class II major histocompatibility complex molecules. | Q54636938 | ||
Systemic Immune Deviation in the Brain That Does Not Depend on the Integrity of the Blood-Brain Barrier | Q56805855 | ||
IFN-gamma-activated primary murine astrocytes express B7 costimulatory molecules and prime naive antigen-specific T cells | Q56908628 | ||
TLR signaling tailors innate immune responses in human microglia and astrocytes | Q57041985 | ||
Naive T lymphocytes traffic to inflamed central nervous system, but require antigen recognition for activation | Q57042465 | ||
Immune invasion of the central nervous system parenchyma and experimental allergic encephalomyelitis, but not leukocyte extravasation from blood, are prevented in macrophage-depleted mice | Q57042734 | ||
Local enhancement of major histocompatibility complex (MHC) class I and II expression and cell infiltration in experimental allergic encephalomyelitis around axotomized motor neurons | Q57352018 | ||
Astrocytes present myelin basic protein to encephalitogenic T-cell lines | Q59059821 | ||
Enhancement of experimental allergic encephalomyelitis in mice by antibodies against IFN-gamma | Q70379216 | ||
Investigation on the expression of major histocompatibility complex class II and cytokines and detection of HIV-1 DNA within brains of asymptomatic and symptomatic HIV-1-positive patients | Q71345946 | ||
Characterization and distribution of phagocytic macrophages in multiple sclerosis plaques | Q72091992 | ||
HLA class II molecules (HLA-DR, -DP, -DQ) on cells in the human CNS studied in situ and in vitro | Q72462837 | ||
Blood monocytes and spleen macrophages differentiate into microglia-like cells on monolayers of astrocytes: membrane currents | Q72630579 | ||
Human microglial cells have phenotypic and functional characteristics in common with both macrophages and dendritic antigen-presenting cells | Q72896286 | ||
Astrocytes and central nervous system endothelial cells do not express B7-1 (CD80) or B7-2 (CD86) immunoreactivity during experimental autoimmune encephalomyelitis | Q73056300 | ||
IFN-gamma is critical to the control of murine autoimmune encephalomyelitis and regulates both in the periphery and in the target tissue: a possible role for nitric oxide | Q73160690 | ||
Studies on the problem of corneal homografts | Q73219232 | ||
CD40 engagement stimulates IL-12 p70 production by human microglial cells: basis for Th1 polarization in the CNS | Q73336410 | ||
Autoimmune intervention by CD154 blockade prevents T cell retention and effector function in the target organ | Q73400740 | ||
Myelin antigen-specific CD8+ T cells are encephalitogenic and produce severe disease in C57BL/6 mice | Q73966732 | ||
Immunopathogenesis of multiple sclerosis: MBP and beyond | Q74307292 | ||
Inflammation and atrophy in multiple sclerosis: MRI associations with disease course | Q74458832 | ||
Presentation of proteolipid protein epitopes and B7-1-dependent activation of encephalitogenic T cells by IFN-gamma-activated SJL/J astrocytes | Q74515347 | ||
Central nervous system microglial cell activation and proliferation follows direct interaction with tissue-infiltrating T cell blasts | Q74597390 | ||
Myelin basic protein in CSF as indicator of disease activity in multiple sclerosis | Q77377216 | ||
IL-12p35-deficient mice are susceptible to experimental autoimmune encephalomyelitis: evidence for redundancy in the IL-12 system in the induction of central nervous system autoimmune demyelination | Q78626045 | ||
Specificity, magnitude, and kinetics of MOG-specific CD8+ T cell responses during experimental autoimmune encephalomyelitis | Q81129297 | ||
EAE in beta-2 microglobulin-deficient mice: axonal damage is not dependent on MHC-I restricted immune responses | Q81662114 | ||
CD95-CD95L: can the brain learn from the immune system? | Q41733641 | ||
Antigen presentation by human fetal astrocytes with the cooperative effect of microglia or the microglial-derived cytokine IL-1. | Q42490295 | ||
Failure to suppress the expansion of the activated CD4 T cell population in interferon gamma-deficient mice leads to exacerbation of experimental autoimmune encephalomyelitis | Q42753284 | ||
Requirement for Θ-Bearing Cells in Lymphocytic Choriomeningitis Virus-induced Central Nervous System Disease | Q44188481 | ||
Experimental autoimmune encephalomyelitis repressed by microglial paralysis. | Q45235066 | ||
Functional activation of myelin-specific T cells by virus-induced molecular mimicry | Q45731233 | ||
Targeting gene-modified hematopoietic cells to the central nervous system: use of green fluorescent protein uncovers microglial engraftment. | Q45881740 | ||
Vasoactive intestinal polypeptide inhibits the expression of the MHC class II antigens on astrocytes | Q46426276 | ||
Mature microglia resemble immature antigen-presenting cells | Q46471783 | ||
Indolamine 2,3-dioxygenase is expressed in the CNS and down-regulates autoimmune inflammation | Q46531302 | ||
Naive versus memory CD4 T cell response to antigen. Memory cells are less dependent on accessory cell costimulation and can respond to many antigen-presenting cell types including resting B cells | Q46681487 | ||
Targeting of adoptively transferred experimental allergic encephalitis lesion at the sites of wallerian degeneration. | Q46708317 | ||
In vivo detection of myelin proteins in cervical lymph nodes of MS patients using ultrasound-guided fine-needle aspiration cytology | Q47288465 | ||
Kinetics of expression of costimulatory molecules and their ligands in murine relapsing experimental autoimmune encephalomyelitis in vivo. | Q47757443 | ||
Passive or active immunization with myelin basic protein impairs neurological function and exacerbates neuropathology after spinal cord injury in rats. | Q47763732 | ||
Astrocytic factors deactivate antigen presenting cells that invade the central nervous system. | Q47820908 | ||
Relative efficiency of microglia, astrocytes, dendritic cells and B cells in naive CD4+ T cell priming and Th1/Th2 cell restimulation | Q48099875 | ||
FasL (CD95L, Apo1L) is expressed in the normal rat and human brain: evidence for the existence of an immunological brain barrier | Q48166557 | ||
Lymphocyte targeting of the brain in adoptive transfer cryolesion-EAE. | Q48188763 | ||
Antigen presentation and tumor cytotoxicity by interferon-gamma-treated microglial cells | Q48215877 | ||
Distribution and phenotype of dendritic cells and resident tissue macrophages in the dura mater, leptomeninges, and choroid plexus of the rat brain as demonstrated in wholemount preparations | Q48250691 | ||
Blocking OX-40/OX-40 ligand interaction in vitro and in vivo leads to decreased T cell function and amelioration of experimental allergic encephalomyelitis. | Q48286199 | ||
A revised view of the central nervous system microenvironment and major histocompatibility complex class II antigen presentation | Q48349929 | ||
Cervical lymphatics, the blood-brain barrier and the immunoreactivity of the brain: a new view | Q48400195 | ||
Interactions between hemopoietically derived TNF and central nervous system-resident glial chemokines underlie initiation of autoimmune inflammation in the brain | Q48430048 | ||
Transfer of central nervous system autoantigens and presentation in secondary lymphoid organs | Q48451211 | ||
Immune regulation by brain cells in the central nervous system: microglia but not astrocytes present myelin basic protein to encephalitogenic T cells under in vivo-mimicking conditions | Q48476538 | ||
Bacillus Calmette-Guérin sequestered in the brain parenchyma escapes immune recognition | Q48495713 | ||
Mouse resident microglia: isolation and characterization of immunoregulatory properties with naïve CD4+ and CD8+ T-cells | Q48501197 | ||
Ia expression and antigen presentation by glia: strain and cell type-specific differences among rat astrocytes and microglia | Q48587633 | ||
Role of cervical lymph nodes in autoimmune encephalomyelitis in the Lewis rat. | Q48642423 | ||
How to drain without lymphatics? Dendritic cells migrate from the cerebrospinal fluid to the B-cell follicles of cervical lymph nodes | Q48744849 | ||
Comparison of phenotypic and functional properties of immediately ex vivo and cultured human adult microglia | Q48926167 | ||
Turnover of rat brain perivascular cells | Q48946702 | ||
P433 | issue | 7 | |
P304 | page(s) | 532-543 | |
P577 | publication date | 2006-06-14 | |
P1433 | published in | Journal of Molecular Medicine | Q6295593 |
P1476 | title | Antigen presentation in autoimmunity and CNS inflammation: how T lymphocytes recognize the brain | |
P478 | volume | 84 |
Q42290435 | A Rare Presentation of Encephalopathy in a 3-Year-Old Child |
Q33367112 | A beta-lactam antibiotic dampens excitotoxic inflammatory CNS damage in a mouse model of multiple sclerosis |
Q35700368 | A lifespan approach to neuroinflammatory and cognitive disorders: a critical role for glia |
Q33930062 | Act1 mediates IL-17-induced EAE pathogenesis selectively in NG2+ glial cells |
Q28477723 | Amelioration of experimental autoimmune encephalomyelitis by plumbagin through down-regulation of JAK-STAT and NF-κB signaling pathways |
Q48849720 | An optimized protocol for the acute isolation of human microglia from autopsy brain samples |
Q34473891 | Anamnestic recall of stroke-related deficits: an animal model. |
Q37971896 | Animal Models of MS Reveal Multiple Roles of Microglia in Disease Pathogenesis |
Q58560818 | Antigen-presenting cell diversity for T cell reactivation in central nervous system autoimmunity |
Q37776438 | Antimicrobial Peptides in the Brain |
Q33702321 | Apolipoprotein E mediation of neuro-inflammation in a murine model of multiple sclerosis |
Q26774826 | Are Microglial Cells the Regulators of Lymphocyte Responses in the CNS? |
Q34777465 | Astrocyte-restricted ablation of interleukin-17-induced Act1-mediated signaling ameliorates autoimmune encephalomyelitis |
Q37525226 | Astrocytes modulate the polarization of CD4+ T cells to Th1 cells. |
Q35613006 | B cell antigen presentation is sufficient to drive neuroinflammation in an animal model of multiple sclerosis |
Q48585444 | B7-H1 and CD8+ Treg: the enigmatic role of B7-H1 in peripheral tolerance |
Q44822884 | B7-H1 restricts neuroantigen-specific T cell responses and confines inflammatory CNS damage: implications for the lesion pathogenesis of multiple sclerosis |
Q35185219 | CCR2-dependent dendritic cell accumulation in the central nervous system during early effector experimental autoimmune encephalomyelitis is essential for effector T cell restimulation in situ and disease progression |
Q37990784 | CXCL12 in control of neuroinflammation. |
Q37986999 | Cancer immunoediting in malignant glioma |
Q36956709 | Cellular approaches for stimulating CNS remyelination |
Q37326668 | Chemokines are associated with delirium after cardiac surgery |
Q24647650 | Collateral bystander damage by myelin-directed CD8+ T cells causes axonal loss |
Q37704340 | Comparison of microglia and infiltrating CD11c⁺ cells as antigen presenting cells for T cell proliferation and cytokine response. |
Q41141797 | Crosstalk with Inflammatory Macrophages Shapes the Regulatory Properties of Multipotent Adult Progenitor Cells. |
Q37863274 | Cytokines and effector T cell subsets causing autoimmune CNS disease |
Q92149773 | Diagnostic Considerations in Acute Disseminated Encephalomyelitis and the Interface with MOG Antibody |
Q82614887 | Early influx of macrophages determines susceptibility to experimental allergic encephalomyelitis in Dark Agouti (DA) rats |
Q59070288 | Effector T cell interactions with meningeal vascular structures in nascent autoimmune CNS lesions |
Q38838452 | Estrogens, Neuroinflammation, and Neurodegeneration. |
Q37130888 | Evaluating epigenetic landmarks in the brain of multiple sclerosis patients: a contribution to the current debate on disease pathogenesis |
Q85241588 | Evidence of hypothalamic degeneration in the anorectic anx/anx mouse |
Q79808383 | Experimental immunology in Zürich: the legacy of studying disease-related Ag |
Q53357929 | Expression of the HGF receptor c-met by macrophages in experimental autoimmune encephalomyelitis. |
Q35162073 | Features of microglia and neuroinflammation relevant to environmental exposure and neurotoxicity |
Q37347661 | Feridex preloading permits tracking of CNS-resident macrophages after transient middle cerebral artery occlusion |
Q24615166 | Focus on TILs: Prognostic significance of tumor infiltrating lymphocytes in human glioma |
Q37290573 | Functional blocking monoclonal antibodies against IL-12p40 homodimer inhibit adoptive transfer of experimental allergic encephalomyelitis |
Q35589270 | Heme oxygenase-1 and carbon monoxide suppress autoimmune neuroinflammation |
Q34475107 | Hydrogen rich saline reduces immune-mediated brain injury in rats with acute carbon monoxide poisoning |
Q33766764 | IL-17 induced NOTCH1 activation in oligodendrocyte progenitor cells enhances proliferation and inflammatory gene expression |
Q37865163 | IL-17 receptor signaling and T helper 17-mediated autoimmune demyelinating disease |
Q58573409 | Immune Checkpoints and Innovative Therapies in Glioblastoma |
Q35784305 | Immune modulation by Lacto-N-fucopentaose III in experimental autoimmune encephalomyelitis. |
Q35501569 | Immunomodulation of experimental allergic encephalomyelitis by cinnamon metabolite sodium benzoate |
Q47613084 | Impact of peripheral immune status on central molecular responses to facial nerve axotomy |
Q45463857 | In acute experimental autoimmune encephalomyelitis, infiltrating macrophages are immune activated, whereas microglia remain immune suppressed. |
Q64085160 | Induction of NTPDase1/CD39 by Reactive Microglia and Macrophages Is Associated With the Functional State During EAE |
Q48097224 | Inhibition of experimental autoimmune encephalomyelitis by tolerance-promoting DNA vaccination focused to dendritic cells. |
Q34140567 | Intracerebral dendritic cells critically modulate encephalitogenic versus regulatory immune responses in the CNS. |
Q37534403 | Invariant NKT cells regulate the CD8 T cell response during Theiler's virus infection |
Q37810517 | Janus head: the dual role of HLA-G in CNS immunity |
Q34645411 | Limited sufficiency of antigen presentation by dendritic cells in models of central nervous system autoimmunity. |
Q36551019 | MicroRNA dysregulation in multiple sclerosis |
Q88637204 | MicroRNA signature of central nervous system-infiltrating dendritic cells in an animal model of multiple sclerosis |
Q37333298 | Microglia: gatekeepers of central nervous system immunology. |
Q36187720 | Migration of monocytes after intracerebral injection |
Q37608080 | Modeling multiple sclerosis in laboratory animals. |
Q33793559 | Modulation of cannabinoid receptor activation as a neuroprotective strategy for EAE and stroke |
Q37909028 | Modulation of dendritic cell function by PGE2 and DHA: a framework for understanding the role of dendritic cells in neuroinflammation |
Q37788598 | Multiple Sclerosis Therapies: Molecular Mechanisms and Future |
Q27023735 | Multiple sclerosis: molecular mechanisms and therapeutic opportunities |
Q33772195 | Myelin recovery in multiple sclerosis: the challenge of remyelination |
Q28269903 | Neuroimmune crosstalk in the central nervous system and its significance for neurological diseases |
Q21245240 | Neuromyelitis optica pathogenesis and aquaporin 4 |
Q37057309 | New developments in understanding and treating neuroinflammation. |
Q83235704 | New directions in multiple sclerosis therapy: matching therapy with pathogenesis |
Q30495158 | Nicotinic acid adenine dinucleotide phosphate-mediated calcium signalling in effector T cells regulates autoimmunity of the central nervous system. |
Q80696235 | Optimized isolation enables ex vivo analysis of microglia from various central nervous system regions |
Q37231755 | PPAR Regulation of Inflammatory Signaling in CNS Diseases |
Q38008365 | Pathogenic CD8 T cells in multiple sclerosis and its experimental models |
Q42439736 | Perivascular spaces--MRI marker of inflammatory activity in the brain? |
Q48458622 | Phenotyping primary human microglia: tight regulation of LPS responsiveness. |
Q38096246 | Polarization of macrophages and microglia in inflammatory demyelination |
Q41528091 | Postulated vasoactive neuropeptide immunopathology affecting the blood-brain/blood-spinal barrier in certain neuropsychiatric fatigue-related conditions: A role for phosphodiesterase inhibitors in treatment? |
Q38620084 | Principles of immunology and its nuances in the central nervous system |
Q34247796 | S-nitrosoglutathione a physiologic nitric oxide carrier attenuates experimental autoimmune encephalomyelitis |
Q36273819 | Self-reactive CD4(+) T cells activated during viral-induced demyelination do not prevent clinical recovery |
Q37240246 | Sensing the microenvironment of the central nervous system: immune cells in the central nervous system and their pharmacological manipulation |
Q45959674 | Significance of Virchow-Robin spaces in patients newly diagnosed with multiple sclerosis: a case-control study in an Arab population. |
Q36298402 | Silencing of Abcc8 or inhibition of newly upregulated Sur1-Trpm4 reduce inflammation and disease progression in experimental autoimmune encephalomyelitis |
Q35990060 | Sodium benzoate, a food additive and a metabolite of cinnamon, modifies T cells at multiple steps and inhibits adoptive transfer of experimental allergic encephalomyelitis |
Q33911929 | Spinal motoneuron synaptic plasticity after axotomy in the absence of inducible nitric oxide synthase |
Q36150477 | Spontaneous inflammatory pain model from a mouse line with N-ethyl-N-nitrosourea mutagenesis. |
Q36362639 | Subcutaneous Transplantation of Neural Precursor Cells in Experimental Autoimmune Encephalomyelitis Reduces Chemotactic Signals in the Central Nervous System |
Q34319616 | T cells promote the regeneration of neural precursor cells in the hippocampus of Alzheimer's disease mice |
Q33593098 | T cells specifically targeted to amyloid plaques enhance plaque clearance in a mouse model of Alzheimer's disease |
Q54558041 | The adaptor Act1 is required for interleukin 17-dependent signaling associated with autoimmune and inflammatory disease. |
Q28240807 | The blood-spinal cord barrier: morphology and clinical implications |
Q27346351 | The experimental autoimmune encephalomyelitis disease course is modulated by nicotine and other cigarette smoke components |
Q37857982 | The immunopathophysiology of multiple sclerosis |
Q37478939 | The kinetics of myelin antigen uptake by myeloid cells in the central nervous system during experimental autoimmune encephalomyelitis |
Q34024675 | The myeloid cells of the central nervous system parenchyma |
Q36027486 | The structural and functional role of myelin fast-migrating cerebrosides: pathological importance in multiple sclerosis. |
Q26999245 | Therapeutic potential of carbon monoxide in multiple sclerosis |
Q37839130 | Treating inflammation in childhood neurodegenerative disorders |
Q30743356 | Tuftsin-driven experimental autoimmune encephalomyelitis recovery requires neuropilin-1. |
Q40518960 | Uptake of parasite-derived vesicles by astrocytes and microglial phagocytosis of infected erythrocytes may drive neuroinflammation in cerebral malaria |
Q34193600 | Vascular aspects of multiple sclerosis. |
Q37419058 | alpha4-Integrin antagonism with natalizumab: effects and adverse effects |
Search more.